Cefuroxime in the treatment of neonates.

Author: HurleyR, MulhallA, de LouvoisJ

Paper Details 
Original Abstract of the Article :
The new broad spectrum cephalosporin, cefuroxime, was used to treat 28 neonates with suspected or proved infection. All of them had had complications at birth or in early neonatal life which were known to predispose to infection. The treatment regimen consisted of intramuscular or intravenous cefuro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863279/

データ提供:米国国立医学図書館(NLM)

Cefuroxime: A Safe and Effective Treatment for Neonates

Infections in newborns can be particularly challenging to treat. This study investigates the use of cefuroxime, a broad-spectrum antibiotic, in treating neonates with suspected or confirmed infections. The researchers found that cefuroxime was safe and effective in treating a wide range of infections in neonates. It was found to be a viable alternative to the traditional combination of gentamicin and penicillin.

Cefuroxime: A Promising Option for Neonatal Infections

The study shows that cefuroxime was well-tolerated by neonates and effectively treated a variety of infections. It demonstrated a significant clinical improvement in 27 out of 28 neonates, highlighting its potential as a reliable treatment option for neonatal infections.

Protecting Our Most Vulnerable

This study underscores the importance of finding safe and effective treatments for infants, who are especially vulnerable to infections. It's a reminder that medical research plays a crucial role in improving healthcare for all ages, including our most vulnerable newborns.

Dr. Camel's Conclusion

This research reminds us that the desert of medicine is constantly expanding. Cefuroxime offers a valuable tool for treating infections in neonates, demonstrating the ongoing advancements in medical care. This study is a testament to the commitment of researchers to protect the health of all, even the most fragile among us.

Date :
  1. Date Completed 1982-05-21
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

7065695

DOI: Digital Object Identifier

PMC2863279

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.